• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

16.86 +0.06 (+0.36%)
Streaming Delayed Price Updated: 2:02 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 56,987
Open 16.92
Bid (Size) 16.84 (400)
Ask (Size) 16.88 (600)
Prev. Close 16.80
Today's Range 16.82 - 16.98
52wk Range 13.77 - 18.91
Shares Outstanding 353,800,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Small-Cap Stocks That Concern Us
September 17, 2026
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
September 11, 2026
From Bausch + Lomb Corporation
Via Business Wire

Performance

YTD
+1.7%
+1.7%
1 Month
-2.3%
-2.3%
3 Month
+6.0%
+6.0%
6 Month
+6.1%
+6.1%
1 Year
+12.3%
+12.3%

More News

Read More
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore
September 09, 2026
Via StockStory
News headline image
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
September 02, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
September 01, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
August 28, 2026
Via StockStory
News headline image
3 Healthcare Stocks We Steer Clear Of
August 27, 2026
Via StockStory
News headline image
Bausch + Lomb Advances Two Eye Therapies With Blockbuster Sales Potential ↗
August 25, 2026
Via Benzinga
News headline image
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q2 Earnings: Bausch + Lomb (NYSE:BLCO) Vs The Rest Of The Pack
August 24, 2026
Via StockStory
News headline image
Bausch + Lomb Advances Dry Eye Drug to Phase III as Pain Candidate Hits Phase Ib Goal ↗
August 24, 2026
Via MarketBeat
News headline image
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
August 24, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
3 Stocks Under $50 We’re Skeptical Of
August 18, 2026
Via StockStory
News headline image
Insider Sheds Nearly 53,000 Shares of Consumer Health Stock, Valued at Almost $900,000 ↗
August 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Bausch + Lomb (BLCO) Q2 2026 Earnings Call Transcript ↗
August 07, 2026
Via The Motley Fool
Topics Earnings
News headline image
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
August 06, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Q2 Earnings Call Highlights ↗
July 29, 2026
Via MarketBeat
Topics Earnings
News headline image
Bausch + Lomb (NYSE:BLCO) Exceeds Q2 CY2026 Expectations
July 29, 2026
Via StockStory
News headline image
Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance
July 29, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect
July 27, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons to Avoid BLCO and 1 Stock to Buy Instead
July 22, 2026
Via StockStory
Topics Stocks
News headline image
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
July 16, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today
July 10, 2026
Via StockStory
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 09, 2026
From Bausch + Lomb
Via Business Wire
News headline image
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
July 09, 2026
From Bausch + Lomb
Via Business Wire
News headline image
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
July 06, 2026
From Bausch + Lomb Corporation
Via Business Wire

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 16.86
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 09/25/26 02:02 PM ET
What is the market capitalization of Bausch + Lomb Corporation Common Shares?
The market capitalization of Bausch + Lomb Corporation Common Shares is 5.97B
How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
Bausch + Lomb Corporation Common Shares has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap